Search Results

Cellecta, Inc. today announced the launch of the DriverMap™ Adaptive Immune Receptor (AIR) Human RNA Spike-In Premixed Controls, the first commercially available collection of synthetic mRNA constructs that can serve as universal controls for commercial or home-brewed AIR repertoire sequencing (AIR-Seq, TCR-seq and BCR-seq) assays based on multiplex RT-PCR or 5' RACE PCR techniques.

American Aires Inc. (CSE: WIFI) (OTCQB: AAIRF) (“Aires” or the “Company”), a pioneer in innovative technology designed to safeguard against electromagnetic radiation and enhance human well-being, issues this news release in order to clarify certain financial disclosure contained in its news release dated June 18, 2024 (the “June 18th Press Release”).

UFC®, the world’s premier mixed martial arts organization, and American Aires Inc. (CSE: WIFI) (OTCQB: AAIRF) (Aires Tech or Aires), a pioneer in cutting-edge technology designed to protect against electromagnetic radiation and optimize human health, today announced a new global marketing partnership that will showcase Aires Tech branding within UFC’s biggest events.

American Aires Inc. (CSE: WIFI) (OTCQB: AAIRF) (“Aires” or the “Company”), a pioneer in cutting-edge technology designed to protect against electromagnetic

Beyond Air, Inc. (NASDAQ: XAIR) (“Beyond Air” or the “Company”) today announced its financial results for the fiscal fourth quarter and year ended March 31, 2024, and provided a corporate update.

American Aires Inc. (CSE: WIFI) (OTCQB: AAIRF) (“Aires” or the “Company”), a pioneer in innovative technology designed to safeguard against electromagnetic radiation and enhance human well-being, is pleased to share a corporate update highlighting the Company’s strong growth and promising future outlook. Despite recent stock price fluctuations, Aires’ fundamentals remain solid, and the Company continues to execute its strategic plan with precision and vigor.